Raphael Pharmaceutical Inc. (RAPH)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
As of 09:39AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 30.60M |
| Enterprise Value | 30.32M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 304.45 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.01 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | -18.00% |
| S&P500 52-Week Change 3 | 23.49% |
| 52 Week High 3 | 2.3000 |
| 52 Week Low 3 | 0.6000 |
| 50-Day Moving Average 3 | 1.0992 |
| 200-Day Moving Average 3 | 1.0272 |
Share Statistics
| Avg Vol (3 month) 3 | 45 |
| Avg Vol (10 day) 3 | 323 |
| Shares Outstanding 5 | 18.66M |
| Implied Shares Outstanding 6 | 18.66M |
| Float 8 | 15.74M |
| % Held by Insiders 1 | 51.99% |
| % Held by Institutions 1 | 0.00% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -236.61% |
| Return on Equity (ttm) | -688.47% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1.28M |
| Diluted EPS (ttm) | -0.0800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 230k |
| Total Cash Per Share (mrq) | 0.01 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.68 |
| Book Value Per Share (mrq) | 0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1.2M |
| Levered Free Cash Flow (ttm) | -814k |
© 2024 Yahoo. All rights reserved.